Related Funds
Fund Name | Location |
Bank of Fukuoka | Fukuoka, Fukuoka Prefecture, Japan |
Chowning Group | Houston, Texas, United States |
Cobalt Ventures | California, San Francisco, United States |
Commonwealth Energy Fund | - |
Commonwealth Seed Capital | Frankfort, Kentucky, United States |
Cox Communications | Atlanta, Georgia, United States |
Delin Ventures | England, London, United Kingdom |
DFS Lab | Seattle, United States, Washington |
Draper B1 | Comunidad Valenciana, Spain, Valencia |
DROIA | Luxembourg, Luxembourg |
Gould Investments | Great Neck, New York, United States |
HNA Technic | China, Haikou, Hainan |
Independence Blue Cross | Pennsylvania, Philadelphia, United States |
Integra Ventures | Seattle, United States, Washington |
Kruger Corporation | - |
Leading Investment & Securities Co. | Seoul, Seoul-t'ukpyolsi, South Korea |
Massar International | Portugal, Santarém, Santarem |
SLS Invest | - |
Stahl Invest | - |
XP Inc | Dallas, Texas, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Cotiss | $2M | 15 May 2023 | Auckland, Auckland, New Zealand | ||
envoyatHome | 18 Jan 2022 | New Jersey, United States | |||
Pera Labs | $50K | 01 Mar 2020 | Philadelphia, Pennsylvania, United States | ||
Recensa Therapeutics | $50K | 13 Jun 2017 | Philadelphia, Pennsylvania, United States | ||
Recensa Therapeutics | $27K | 16 Jun 2016 | Philadelphia, Pennsylvania, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Cotiss | $2M | 15 May 2023 | Auckland, Auckland, New Zealand | ||
envoyatHome | 18 Jan 2022 | New Jersey, United States | |||
Pera Labs | $50K | 01 Mar 2020 | Philadelphia, Pennsylvania, United States | ||
Recensa Therapeutics | $50K | 13 Jun 2017 | Philadelphia, Pennsylvania, United States | ||
Recensa Therapeutics | $27K | 16 Jun 2016 | Philadelphia, Pennsylvania, United States |